🔎 Trials Near Me

ホーム › 肥満症 › テキサス › Houston

Houston、TXにおける肥満症の臨床試験

Houstonとその周辺地域(約30マイル以内)の拠点で、肥満症に関する43件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第2相
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · 7マイル先
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

被験者募集中第2相
  • Cardiovascular Specialists of Willowbrook, Houston
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

被験者募集中第3相
  • PlanIt Research, PLLC, Houston
18歳以上 · 全性別 · 2026/09/30更新 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

被験者募集中第3相
  • DM Clinical, Houston
8歳〜18歳 · 全性別 · 2026/09/30更新 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

被験者募集中第3相
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

被験者募集中第3相
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

被験者募集中第3相
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • 他1件
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

被験者募集中第3相
  • Juno Research, Houston
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

被験者募集中第3相
  • Juno Research, Houston
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

被験者募集中第3相
  • Research Site, Houston
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

被験者募集中第3相
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • 他2件
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

被験者募集中第3相
  • The University of Texas Health Science Center at Houston, Bellaire · 7マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

被験者募集中第3相
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • PlanIt Research, PLLC, Houston
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

被験者募集中第2相健康なボランティア歓迎
  • The University of Texas Health Science Center at Houston, Houston
18歳〜75歳 · 全性別 · 2026/09/21更新 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

被験者募集中第3相
  • AURORA-2 Clinical Site, Houston
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

被験者募集中第3相
  • East Texas Cardiology PA, Houston
  • Biopharma Informatic, Houston
  • Orion Medical, Houston
  • 他3件
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

被験者募集中第3相
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

被験者募集中第2相
  • Juno Research, Houston
18歳〜75歳 · 全性別 · 2026/09/14更新 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

被験者募集中第3相
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7マイル先
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

被験者募集中第3相健康なボランティア歓迎
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • PlanIt Research, PLLC, Houston
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

被験者募集中第2相
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

被験者募集中第4相
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7マイル先
18歳以上 · 全性別 · 2026/09/04更新 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

被験者募集中第3相
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7マイル先
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

被験者募集中第3相
  • Kailera Clinical Site, Bellaire · 7マイル先
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

被験者募集中第3相
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7マイル先
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

被験者募集中第3相
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
18歳〜99歳 · 全性別 · 2026/08/27更新 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

被験者募集中第3相
  • Research Site, Houston
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

被験者募集中第2相
  • Baylor Texas Children's Hospital, Houston
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

被験者募集中第3相
  • East Texas Cardiology PA, Houston
  • Victorium Clinical Research, Houston
  • Main Heart Clinic, Houston
  • 他1件
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

被験者募集中第3相
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

被験者募集中健康なボランティア歓迎
  • Children's Nutrition Research Center, Houston
12歳〜18歳 · 全性別 · 2026/07/07更新 · NCT06959901

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

被験者募集中健康なボランティア歓迎参加者への支払いあり
  • USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
14歳〜16歳 · 全性別 · 2026/07/07更新 · NCT06943001

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

被験者募集中観察研究健康なボランティア歓迎
  • Lilli Health, Houston
18歳以上 · 全性別 · 2026/05/01更新 · NCT05950282

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

被験者募集中
  • M D Anderson Cancer Center, Houston
18歳以上 · 女性 · 2026/04/21更新 · NCT04003038

Incretin Microdosing for Cardiometabolic Health in People With HIV

被験者募集中第2相
  • The University of Texas Health Science Center at Houston, Houston
18歳以上 · 全性別 · 2026/02/18更新 · NCT07325500

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

被験者募集中第2相
  • Baylor College of Medicine, Houston
18歳以上 · 全性別 · 2026/01/16更新 · NCT06273072

RESET System Pivotal Trial (Rev F)

被験者募集中
  • Baylor College of Medicine, Houston
22歳〜65歳 · 全性別 · 2024/07/18更新 · NCT04101669

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

被験者募集中
  • Houston Methodist Hospital, Houston
18歳以上 · 全性別 · 2024/04/01更新 · NCT06339320

他の都市における肥満症の試験

Houstonにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。